Atrial fibrillation phenotypes: the route to personalised care?

Arunashis Sau^{1

2}, Libor Pastika^{1

3}, Fu Siong Ng^{4

2

3}

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London, UK.
² Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.
³ Department of Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
⁴ National Heart and Lung Institute, Imperial College London, London, UK f.ng@imperial.ac.uk.

Editorial

Arunashis Sau et al. Heart. 2023.

. 2023 Nov 10;109(23):1727-1728.

doi: 10.1136/heartjnl-2023-322812.

Arunashis Sau^{1

2}, Libor Pastika^{1

3}, Fu Siong Ng^{4

2

3}

¹ National Heart and Lung Institute, Imperial College London, London, UK.
² Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.
³ Department of Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
⁴ National Heart and Lung Institute, Imperial College London, London, UK f.ng@imperial.ac.uk.

No abstract available

Keywords: Atrial Fibrillation.

Conflict of interest statement

Competing interests: FSN is an inventor of a patent application on Granger Causality mapping.

Phenotyping of atrial fibrillation with cluster analysis and external validation.
Saito Y, Omae Y, Nagashima K, Miyauchi K, Nishizaki Y, Miyazaki S, Hayashi H, Nojiri S, Daida H, Minamino T, Okumura Y. Saito Y, et al. Heart. 2023 Nov 10;109(23):1751-1758. doi: 10.1136/heartjnl-2023-322447. Heart. 2023. PMID: 37263768 Free PMC article.